Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Journal of Health Study and Medicine
Volume 2023 (2023): Issue 1 (January 2023)
Open Access
What Do We Know about Flozins: New, Pleiotropic Drugs
Eliza Wojciechowska
Eliza Wojciechowska
and
Bogusław Okopień
Bogusław Okopień
| Feb 24, 2024
Journal of Health Study and Medicine
Volume 2023 (2023): Issue 1 (January 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 24, 2024
Page range:
247 - 273
Received:
Aug 28, 2023
Accepted:
Jan 10, 2024
DOI:
https://doi.org/10.2478/jhsm-2023-0013
Keywords
flozins
,
SGLT2-i
,
diabetes
,
inflammation
,
cardiovascular risk
© 2023 Eliza Wojciechowska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Eliza Wojciechowska
Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia
Katowice, Poland
Bogusław Okopień
Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia
Katowice, Poland